Stomach problems, sometimes severe, have been reported in people who use Saxenda
Medicares pilot program (if implemented) could give insights on how to deliver these drugs under government plans
Their change in creatinine was compared to patients with no GLP-1 exposure who had office visits in the same period
Drucker DJ, Nauck MA: The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes
The Hidden Risk in Pure GLP-1 Exposure The danger for investors concentrated in prescription-only models is real: discontinuation risk, attrition risk, and a growing clinical consensus that medication without infrastructure produces fragile outcomes
The 503B outsourcing facilities registered with the FDA follow stricter manufacturing requirements similar to those of regular drug manufacturers, though they bypass the pre-market review and batch-release testing required for FDA-approved products